Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Blood Collection Monitor Market size was over USD 142.79 million in 2024 and is poised to exceed USD 319.84 million by 2037, growing at over 6.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of blood collection monitor is evaluated at USD 150.56 million.
The growth of the market can be attributed to the increasing prevalence of blood disorders, which in turn is evaluated to raise the demand for blood transfusion therapies. In 2019, about 200,000 people in the world were diagnosed with hemophilia and about 81,000 with von Willebrand disease, both of which are common types of bleeding disorders. Along with these, growing number of critical life-saving surgical procedures performed globally, especially among geriatric population who are more prone to various diseases, is also expected to drive market growth in the forthcoming years. Furthermore, escalating technological advancements in the healthcare sector, particularly in developed and developing nations, for blood collection procedures and products is projected to offer profitable opportunities to the blood collection monitor market in the near future.
Blood Collection Monitor Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Prevalence of Blood Disorders
- Growing Number of Critical Life-Saving Surgical Procedures Performed Globally
Challenges
- High Cost of Automated Blood Collection Monitors
Blood Collection Monitor Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
6.4% |
Base Year Market Size (2024) |
USD 142.79 million |
Forecast Year Market Size (2037) |
USD 319.84 million |
Regional Scope |
|
Blood Collection Monitor Segmentation
The market is segmented by end user into hospitals, research clinics, laboratories, and others, out of which, the hospitals segment is anticipated to hold the largest share in the global blood collection monitor market. This can be accounted to the increasing number of cases of infectious diseases and trauma cases, which in turn is predicted to ensure the demand for blood collection devices and equipment in hospital facilities. Additionally, on the basis of calibration type, the automated weight calibration segment is assessed to observe significant growth during the forecast period, which can be credited to the fact that automating weight calibration minimize errors such as imprecise placement and weight mix-ups.
Our in-depth analysis of the global market includes the following segments:
By Calibration Type |
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportBlood Collection Monitor Industry - Regional Synopsis
Regionally, the global blood collection monitor market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in Asia Pacific industry is set to hold largest revenue share by 2037, propelled by high geriatric population, along with rising cases of asthma, as older people are more vulnerable to respiratory diseases. According to the World Health Organization (WHO), the percentage of people aged 60 years or above was 9.8% in 2017, which is anticipated to increase to 13.7% and 20.3% by 2030 and by 2050, respectively. Moreover, the market in North America is expected to gather the largest share during the forecast period owing to the large number of people undertaking blood transfusion procedures, and high healthcare spending in the region. In addition, strong presence of prominent market players is also projected to fuel the blood collection monitor market growth in the region in the coming years.

Companies Dominating the Blood Collection Monitor Landscape
- Fresenius Kabi AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson and Company
- Grifols S.A.
- Quest Diagnostics, Inc.
- Nipro Medical Corporation
- SARSTEDT AG & Co.
- REMI GROUP
- Bioelettronica S.r.l.
- Delcon SRL
- Haemonetics Corporation
In the News
-
July 2020- Grifols announced the acquisition of 10% stake in Bloodbuy, a cloud-based marketplace that facilitates buying and selling of blood components in the United States.
-
February 2020- Becton Dickinson, and Company declared a strategic partnership with Babson Diagnostics for enabling small-volume blood collection for diagnostic testing in retail pharmacies.
Author Credits: Radhika Pawar
- Report ID: 3992
- Published Date: Dec 26, 2024
- Report Format: PDF, PPT